经典左心发育不良综合征Fontan术后中期结局
该回顾性研究分析了1994至2022年间812例接受心外全腔静脉肺动脉连接术的患者,中位随访10.1年,比较了109例经典左心发育不良综合征(cH组)、205例异位综合征(Hx组)和498例其他单心室病变(O组)的结局。cH组10年和20年生存率均为97.2%,与其他组相似,但再干预自由率较低(10年80.5%,20年55.7%),且最大氧耗下降更快(每年-2.5%)。
要点
- cH组Fontan术后10年和20年生存率均为97.2%,与其他单心室病变相似。
- cH组再干预自由率较低,10年和20年分别为80.5%和55.7%。
- cH组最大氧耗每年下降2.5%,快于O组的0.9%。
核心结论
- 经典左心发育不良综合征患者Fontan术后总体生存率与其他单心室综合征相当,血流动力学良好且中期合并症较低。
- 但肺动脉指数较低、再干预自由率降低和运动耐量进行性下降仍是遗留问题。
研究设计与样本
- 回顾性分析1994至2022年单中心812例接受心外全腔静脉肺动脉连接术的病例,中位随访10.1年。
- 比较109例经典左心发育不良综合征(cH组)、205例异位综合征(Hx组)和498例其他单心室病变(O组)的结局。
主要发现
- cH组10年和20年生存率均为97.2%,各组间相似。
- cH组免于所有Fontan相关事件的比率10年和20年分别为81.2%和68.1%,各组间相似。
- 肝酶变量无显著差异,未观察到肝硬化。
- 术后导管检查显示各组Fontan压力、舒张末期压力、心脏指数和肺血管阻力相似,但cH组肺动脉指数较低。
- cH组再干预自由率10年和20年分别为80.5%和55.7%,低于其他组。
临床怎么用
- cH组Fontan术后中期生存良好,但需关注再干预风险及运动耐量下降,定期评估肺动脉指数和运动能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the outcomes of patients with classical hypoplastic left heart syndrome following extracardiac total cavopulmonary connection. METHODS: We retrospectively analysed 812 cases that underwent extracardiac total cavopulmonary connection at our hospital between 1994 and 2022. With a median follow-up of 10.1 years, we compared the survival rate, Fontan-related events, liver function, postoperative haemodynamics, freedom from reintervention and exercise tolerance in 109 patients with classical hypoplastic left heart syndrome (cH group), 205 patients with heterotaxy (Hx group) and 498 patients with other univentricular conditions (O group). RESULTS: The survival rates (97.2% at 10 and 20 years for the cH group) and freedom rates from all Fontan-related events (81.2% and 68.1%) were similar across groups. Liver enzyme variables did not significantly differ, and liver cirrhosis was not observed. Postoperative catheter examinations showed similar Fontan pressure, end-diastolic pressure, cardiac index and pulmonary vascular resistance across groups, with a lower pulmonary artery index in the cH group. The rates of freedom from reintervention at 10 and 20 years were lower in the cH group (80.5% and 55.7%). Maximal oxygen consumption during cardiopulmonary exercise testing declined faster in the cH group (-2.5% per year) than in the O group (-0.9% per year), with no difference with the Hx group (-2.4% per year). CONCLUSIONS: The overall survival rate of patients with classical hypoplastic left heart syndrome after Fontan procedure was comparable to that of patients with other univentricular syndromes, showing good haemodynamics and lower mid-term comorbidities. However, lower pulmonary artery index, reduced freedom from reintervention and progressive decline in exercise tolerance are remaining concerns.
引用
- Nagase T, Fujita S, Harada T, et al. Mid-term outcomes of classical hypoplastic left heart syndrome after Fontan procedure. Eur J Cardiothorac Surg. 2025. PMID: 40120080. doi:10.1093/ejcts/ezaf052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。